Metformin inhibits growth and prolactin secretion of pituitary prolactinoma cells and xenografts

Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals

(2018) Lara Faggi et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Combination Treatment with Bromocriptine and Metformin in Patients with Bromocriptine-Resistant Prolactinomas: Pilot Study

(2018) Xiaohai Liu et al.   World Neurosurgery

Sex-Dependent Effect of Metformin on Serum Prolactin Levels In Hyperprolactinemic Patients With Type 2 Diabetes: A Pilot Study

(2017) Robert Krysiak et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways

(2017) Shoeb Ikhlas et al.   LIFE SCIENCES

Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells

(2017) Jiayin An et al.   Oncotarget

Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline

(2015) Shao Jian Lin et al.   Oncotarget

Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models

(2014) Lei Cao et al.   JOURNAL OF NEURO-ONCOLOGY

Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK

(2014) X. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

SIRT1 and AMPK Mediate Hypoxia-Induced Resistance of Non-Small Cell Lung Cancers to Cisplatin and Doxorubicin

(2013) D. H. Shin et al.   CANCER RESEARCH

AMPK: A Contextual Oncogene or Tumor Suppressor?

(2013) J. Liang et al.   CANCER RESEARCH

Management of medically refractory prolactinoma

(2013) Mark E. Molitch   JOURNAL OF NEURO-ONCOLOGY

Inhibitory effects of fulvestrant on the growth of estrogen-induced prolactinoma in Fischer 344 rats and its possible mechanism

(2013) Y. Guo et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells

(2012) Giovanni Tulipano et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

(2011) Shlomo Melmed et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Dopamine agonist–resistant prolactinomas

(2011) Michael C. Oh et al.   JOURNAL OF NEUROSURGERY

AMP-activated protein kinase regulates normal rat somatotroph cell function and growth of rat pituitary adenomatous cells

(2011) Giovanni Tulipano et al.   Pituitary

Metformin Decreases GnRH- and Activin-Induced Gonadotropin Secretion in Rat Pituitary Cells: Potential Involvement of Adenosine 5' Monophosphate-Activated Protein Kinase (PRKA)

(2010) L. Tosca et al.   BIOLOGY OF REPRODUCTION

Effects of estrogen receptor antagonist on biological behavior and expression of growth factors in the prolactinoma MMQ cell line

(2010) Hongtao Lv et al.   JOURNAL OF NEURO-ONCOLOGY

The prolactinoma

(2009) Annamaria Colao   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Genes Differentially Expressed in Prolactinomas Responsive and Resistant to Dopamine Agonists

(2008) Vanessa Q. Passos et al.   NEUROENDOCRINOLOGY